Literature DB >> 31581117

AACR Cancer Progress Report 2019: Transforming Lives Through Innovative Cancer Science.

Rajarshi Sengupta1, Karen Honey2.   

Abstract

Year:  2019        PMID： 31581117     DOI： 10.1158/1078-0432.CCR-19-2655

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  4 in total

1.  AraC-FdUMP[10] Is a Next-Generation Fluoropyrimidine with Potent Antitumor Activity in PDAC and Synergy with PARG Inhibition.

Authors:  William H Gmeiner; Jonathan R Brody; Alex O Haber; Aditi Jain; Chinnadurai Mani; Avinoam Nevler; Lebaron C Agostini; Talia Golan; Komaraiah Palle; Charles J Yeo
Journal:  Mol Cancer Res       Date:  2021-02-16       Impact factor: 6.333

Review 2.  Treatment of patients with cancer using PD‑1/PD‑L1 antibodies: Adverse effects and management strategies (Review).

Authors:  Guangshun Sun; Hanyuan Liu; Xuesong Shi; Pengyu Tan; Weiwei Tang; Xin Chen; Guoqiang Sun; Weijun Yang; Xiangyi Kong; Zhiying Zheng; Hongyong Cao; Guoqiang Shao
Journal:  Int J Oncol       Date:  2022-04-29       Impact factor: 5.884

3.  Persistent TLR4 Activation Promotes Hepatocellular Carcinoma Growth through Positive Feedback Regulation by LIN28A/Let-7g miRNA.

Authors:  I-Ting Chen; An-Chieh Cheng; Yi-Ting Liu; Chieh Yan; Yi-Chen Cheng; Chiung-Fang Chang; Ping-Hui Tseng
Journal:  Int J Mol Sci       Date:  2022-07-29       Impact factor: 6.208

4.  Effects of traditional Chinese medicine exercise therapy on cancer-related fatigue, anxiety and sleep quality in cancer patients: A protocol for systematic review and network meta-analysis.

Authors:  Lihao Jiang; Ju Ouyang; Xianfeng Du
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.